Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Change in Receivables (2010 - 2025)

Siga Technologies' (SIGA) quarterly Change in Receivables came in at -$4.0 million in Q3 2025, down 227.49% on a YoY basis from $3.1 million in Q3 2024, and down 471.61% quarter-over-quarter from -$699108.0 in Q2 2025.

Analysis

Siga Technologies (SIGA) Change in Receivables (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Change in Receivables for 16 consecutive years, with -$4.0 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables fell 227.49% year-over-year to -$4.0 million; the trailing twelve-month figure through Sep 2025 stood at -$9.6 million (down 337.66% YoY), and the FY2024 full-year result was $35178.0, up 100.14% from the prior year.
  • Change in Receivables declined to -$4.0 million in Q3 2025 per SIGA's latest filing, from -$699108.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $79.8 million in Q4 2021 and bottomed at -$78.3 million in Q1 2022.
  • Historically, Change in Receivables has averaged -$44738.4 across 5 years, with a median of -$699108.0 in 2025.
  • The widest YoY moves for Change in Receivables: up 1144.17% in 2022, down 11947.51% in 2022.
  • Over 5 years, Change in Receivables stood at $79.8 million in 2021, then tumbled by 111.92% to -$9.5 million in 2022, then soared by 237.42% to $13.1 million in 2023, then plunged by 30.61% to $9.1 million in 2024, then slumped by 144.02% to -$4.0 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods registered -$4.0 million, -$699108.0, and -$14.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 1.35 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 1.37 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 73.80 Mn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -1.70 Mn
10 Siga Technologies 235.60 Mn 80.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -4.00 Mn
Jun 30, 2025 -699,108.00
Mar 31, 2025 -13.98 Mn
Dec 31, 2024 9.08 Mn
Sep 30, 2024 3.13 Mn
Jun 30, 2024 -9.17 Mn
Mar 31, 2024 -3.00 Mn
Dec 31, 2023 13.08 Mn
Sep 30, 2023 2.02 Mn
Jun 30, 2023 -6.29 Mn
Mar 31, 2023 -33.09 Mn
Dec 31, 2022 -9.52 Mn
Sep 30, 2022 35.33 Mn
Jun 30, 2022 14.26 Mn
Mar 31, 2022 -78.31 Mn
Dec 31, 2021 79.83 Mn
Sep 30, 2021 -3.38 Mn
Jun 30, 2021 3.20 Mn
Mar 31, 2021 660,996.00
Dec 31, 2020 -37.06 Mn